By Greg Arnold, DC, CSCS, December 5, 2006, abstracted from Association Between Serum Beta-Carotene Levels and Decline of Cognitive Function in High-Functioning Older Persons With or Without Apolipoprotein E 4 Alleles: MacArthur Studies of Successful Aging in the June 2006 issue of the Journals of Gerontology Series A
Beta-carotene is a member of a class of antioxidants called carotenoids that produce the red, orange, yellow and green colors of vegetables and fruits
1 and joins
lycopene,
2lutein,
3 and
zeaxanthin4 as the main dietary carotenoids.
Research has found that carotenoids produce a number of health benefits, including helping maintain heart,5 eye,6 and cell7 health. Now a new study8 has found that beta-carotene may help maintain mental health as we age.
Study participants included 455 patients aged 65 years or older from the the MacArthur Research Network Study.9 They completed a mental status questionnaire10 and had blood drawn to measure for antioxidant levels as well as the presence of a gene called APOE 4. Research has found the presence of this gene increases the risk for cognitive decline as we age.11
The researchers confirmed previous findings12 showing patients with the APOE 4 gene had lower cognitive scores than those without the APOE 4 gene. They also found that high blood levels of beta-carotene levels elicited a 89% reduction in the risk of cognitive decline in people with at least some expression of the APOE 4 gene. For those with no APOE 4 gene expression, high beta-carotene levels produced an 11% reduction in the risk of cognitive decline.
For the researchers, antioxidants and beta-carotene in particular may offer protection from cognitive decline in persons with
the presence of the APOE 4 [gene].
No recommendations or estimates of beta-carotene intake were made by the researchers. However, current recommendations for beta-carotene intake by the National Institutes of health range from 1,000 IU for children to 4,300 IU for lactating women.13
Reference:
1 Beta Carotene posted on the PDR Health website
2 Limpens J. Combined Lycopene and Vitamin E Treatment Suppresses the Growth of PC-346C Human Prostate Cancer Cells in Nude Mice J. Nutr. 2006 136: 1287-1293
3 Wang M. Antioxidant activity, mutagenicity/anti-mutagenicity, and clastogenicity/anti-clastogenicity of lutein from marigold flowers. Food Chem Toxicol 2006; 44(9): 1522-1529
4 Lidebjer C. Low plasma levels of oxygenated carotenoids in patients with coronary artery disease. Nutr Metab Cardio Dis 2006. In Press, Corrected Proof, Available online 30 June 2006
5 Nurmi T. Carotenoids and cardiovascular health. Am J Clin Nutr. 2006 Jun;83(6):1265-71
6 Stahl W. Macular carotenoids: lutein and zeaxanthin. Dev Ophthalmol. 2005;38:70-88
7 Bertram JS. Cancer prevention by retinoids and carotenoids: independent action on a common target. Biochim Biophys Acta. 2005 May 30;1740(2):170-8. Epub 2005 Jan 25
8 Seeman TE. Association Between Serum Beta-Carotene Levels and Decline of Cognitive Function in High-Functioning Older Persons With or Without Apolipoprotein E 4 Alleles: MacArthur Studies of Successful Aging. J. Gerontol. A Biol. Sci. Med. Sci. 2006 61: 616-620
9 Albert M. el ul. High, usual, and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol. 1993;46:1129-1140
10 Pleiffer F.. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1973;23:433-441
11 Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurohiol Aging. 2004:25: 641-650
12 Limner L. et al. The role of APOE4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology. 2003;60:1077-1081
13 Vitamin A and Carotenoids posted on the Office of Dietary Supplements website